|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn952337018 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160212s2016 nyua ob 001 0 eng |
| 010 |
|
|
|a 2019720647
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d EBLCP
|d N$T
|d OCLCF
|d SNK
|d DKU
|d AUW
|d INTCL
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d OCL
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|
| 020 |
|
|
|z 9781634848794
|
| 020 |
|
|
|z 1634848799
|
| 020 |
|
|
|a 9781634848961
|q epub
|
| 020 |
|
|
|a 1634848969
|
| 029 |
1 |
|
|a AU@
|b 000062420448
|
| 035 |
|
|
|a (OCoLC)952337018
|
| 050 |
0 |
0 |
|a RC953.7
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 615.1084/6
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Optimization of drug prescribing in elderly /
|c Hugo Juárez Olguín and Ismael Lares Asseff, editors.
|
| 264 |
|
1 |
|a New York :
|b Nova Publishers,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Pharmacology-research, safety testing, and regulation
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a OPTIMIZATION OF DRUG PRESCRIBING IN ELDERLY; OPTIMIZATION OF DRUG PRESCRIBING IN ELDERLY; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; AGING, CLINICAL PHARMACOKINETIC AND PERSONALIZED PHARMACOTHERAPY; Chapter 1: WHAT IS THERAPEUTIC OPTIMIZATION SCHEDULE OF DRUGS USED IN ELDERLY?; ABSTRACT; INTRODUCTION; REFERENCES; Chapter 2: OVERVIEW OF THE COMMON GERIATRIC ILLNESS; ABSTRACT; INTRODUCTION; EPIDEMIOLOGY; CLINIC FEATURES OF THE DISEASES IN ELDERLY PEOPLE; GERIATRIC SYNDROMES; SPECIFIC PATHOLOGIES BY ORGANS AND SYSTEMS IN THE ELDERLY PEOPLE
|
| 505 |
8 |
|
|a DISEASES BY ORGANS IN THE ELDERLY PEOPLECONCLUSION; REFERENCES; Chapter 3: EFFECT OF AGE ON THE PHARMACOKINETIC OFDRUGS IN ELDERLY; ABSTRACT; INTRODUCTION; PHARMACOKINETIC CHANGES; VARIATIONS IN THE DISTRIBUTION OF DRUGS; DRUG METABOLISM; EFFECTS ON PROTEIN BINDING; RECEPTOR BINDING; CHANGES IN LIVER FUNCTION; VARIATIONS OF RENAL FUNCTION; RENAL SYSTEM, DRUG AND ELECTROLYTE; DRUG INTERACTIONS; CONCLUSION; REFERENCES; Chapter 4: USEFUL OF THE PHARMACOKINETIC STUDIES AS A BASE FORTHE ESTABLISHMENT OF THERAPEUTIC SCHEDULES; ABSTRACT; INTRODUCTION
|
| 505 |
8 |
|
|a DEFINITIONS AND FUNCTIONS OF CLINICAL PHARMACOKINETICSREFERENCES; Chapter 5: MEANING OF PHARMACOKINETIC PARAMETERS; ABSTRACT; INTRODUCTION; SYSTEMIC BIOAVAILABILITY; BIOLOGICAL HALF-LIFE; APPARENT VOLUME OF DISTRIBUTION; RENAL CLEARANCE; TOTAL CLEARANCE; FACTORS INFLUENCING TREATMENT RESPONSE; REFERENCES; Chapter 6: RELEVANCE OF THE PHARMACOKINETIC APPLIED IN CLINIC; ABSTRACT; INTRODUCTION; MAIN ELEMENTS IN PHARMACOKINETICS; BASICS; MEANING OF THE VOLUME OF DISTRIBUTION IN THE CLINIC; MEANING OF DRUG ELIMINATION IN THE CLINIC; MEANING OF TOTAL CLEARANCE IN THE CLINIC
|
| 505 |
8 |
|
|a MEANING OF DEEP COMPARTMENT IN CLINICPHARMACOKINETICS APPLICATIONS IN CLINIC; REFERENCES; Chapter 7: DIFFERENT METHODS USED TO DETERMINE THE PHARMACOKINETICS PARAMETERS; ABSTRACT; INTRODUCTION; APPLYING THE CONCEPTS TO EVALUATE PHARMACOKINETIC AND OPTIMIZATION OF THERAPEUTIC REGIMENS; DRUG ACCUMULATION; DOSE ADJUSTMENT FOR A THERAPEUTIC REGIMEN OF REPEATED ADMINISTRATION; SUSTAINED THERAPEUTIC CONCENTRATIONS; REFERENCES; Chapter 8: PHARMACOKINETICS STUDIES AND THE INTERPRETATION OF DRUG LEVELS IN STEADY STATE; ABSTRACT; INTRODUCTION; CLINICAL INTERPRETATION OF THE LEVELS IN THE STEADY STATE
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Geriatric pharmacology.
|
| 650 |
|
0 |
|a Scheduling.
|
| 650 |
|
0 |
|a Chemotherapy.
|
| 650 |
|
0 |
|a Older people.
|
| 650 |
|
2 |
|a Drug Therapy
|
| 650 |
|
2 |
|a Aged
|
| 650 |
|
2 |
|a Aged, 80 and over
|
| 650 |
|
6 |
|a Pharmacologie gériatrique.
|
| 650 |
|
6 |
|a Emploi du temps.
|
| 650 |
|
6 |
|a Chimiothérapie.
|
| 650 |
|
6 |
|a Personnes âgées.
|
| 650 |
|
7 |
|a elderly.
|2 aat
|
| 650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
| 650 |
|
7 |
|a Older people.
|2 fast
|0 (OCoLC)fst01199093
|
| 650 |
|
7 |
|a Chemotherapy.
|2 fast
|0 (OCoLC)fst00853595
|
| 650 |
|
7 |
|a Scheduling.
|2 fast
|0 (OCoLC)fst01106653
|
| 650 |
|
7 |
|a Geriatric pharmacology.
|2 fast
|0 (OCoLC)fst00941246
|
| 700 |
1 |
|
|a Juárez Olguín, Hugo,
|e editor.
|
| 700 |
1 |
|
|a Lares Asseff, Ismael,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Optimization of drug prescribing in elderly
|d New York : Nova Publishers, [2016]
|z 9781634848794
|w (DLC) 2016933386
|
| 830 |
|
0 |
|a Pharmacology-research, safety testing, and regulation series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1258668
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1258668
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4591523
|
| 994 |
|
|
|a 92
|b IZTAP
|
